In a small study, intravenous mistletoe extract shows promise as a therapy for patients with advanced and treatment-resistant cancers.

An upgraded model shows how the body's immune response can make tumor cells more resistant to chemotherapy.

Increasingly dense cell clusters in growing tumors convert blood vessels into fiber-​filled channels, research finds.

Newly discovered biomarkers may offer a way to predict if pancreatic cysts will turn to cancer or remain benign.

Interviews with over 90 patients and caregivers in the US and Australia highlight how COVID-19 disrupted cancer care in 2020 and 2021.

New research may explain why some patients with ovarian cancer respond poorly to chemotherapy or relapse after treatment.

More people in the US get cancer screening when employers are mandated to provide paid sick leave, research finds.

Older adults with cancer who take multiple medications have 59% higher odds of having to stop cancer treatment earlier than recommended.

DNA sequencing may provide a more effective way to predict the risk of kidney cancer coming back, researchers report.

Medicaid expansion led to a 1.5% increase in survival of children with cancer. That means 200 more children alive two years after diagnosis.